The complaint against the TPH
36 On 25 October 2012, Dr Ogawa wrote to the Commissioner alleging that the TPH had interfered with her privacy. The Commissioner treated Dr Ogawa's letter as a complaint under s 36 of the Act. Again, that letters is unfortunately not in evidence in this proceeding.
37 It is apparent from the later correspondence that Dr Ogawa's allegation was that the TPH had interfered with her privacy in relation to the disclosure of her personal information by Dr Calvird and Ms Gordge. Dr Ogawa claimed that the TPH was responsible for the conduct of Dr Calvird and Ms Gordge in disclosing her personal information to the CDPP.
38 On 5 November 2012, the Commissioner's delegate wrote to Dr Ogawa expressing an intention to decline to investigate Dr Ogawa's complaint under s 41(1)(a), but inviting Dr Ogawa to provide a response to the letter "before we make a final decision". The Commissioner's view expressed in the delegate's letter was this:
TPH has examined its records for the period 18 December 2008 to February 2009 when you were seeing Dr Calvird. TPH states its records do not indicate you were a patient of TPH during that time.
I note TPH explained to you, in its letter dated 17 October 2012, that the Toowong Specialist Centre was merely leasing space from TPH. The Toowong Specialist Centre did not form part of TPH, and Dr Calvird and Ms Gordge were not working for TPH. Therefore, there is no act or practice by TPH, in this instance, that would constitute an interference of privacy.
In addition, I note that in relation to your complaint against Dr Calvird, the [Commissioner] has previously found the disclosure by Dr Calvird was authorised by law, and was not a breach of the Act.
Other matters
Please note that your complaint against Dr Calvird is closed and the OAIC will not be pursuing that matter any further.
Next steps
On the available information it appears that TPH has met the requirements of the Act. Consequently, we intend to decline to investigate your complaint under s 41(1)(a) …
39 Dr Ogawa responded to the Commissioner. On 18 February 2013, the Commissioner's delegate wrote again to Dr Ogawa addressing the issues raised in Dr Ogawa's response to the first letter, and giving Dr Ogawa a further opportunity to comment before the Commissioner made a final decision. In the letter of 18 February 2013, the delegate referred to s 8(1)(a) of the Act regarding the acts and practices done by employees or agents, and concluded that he was "satisfied that Dr Calvird was not an employee of, or in the service of, [the TPH]". The delegate also noted that, in any case, the Commissioner had previously determined that Dr Calvird did not interfere with Dr Ogawa's privacy, and that that complaint remained closed.
40 In respect of Ms Gordge, however, the delegate considered that the actions of Ms Gordge, in performing duties at the direction of Dr Calvird, "can be considered the actions of the TPH as defined in s 8(1)(a) of the Act" [emphasis added]. The delegate therefore went on to consider whether the TPH had interfered with Dr Ogawa's privacy under the Act in respect of the disclosure made by Ms Gordge to Dr Calvird. In relation to the alleged breach of NPP2, the delegate said this:
It appears TPH collected your personal information from Dr Calvird for the purpose of providing administrative support to Dr Calvird at the Toowong Specialist Centre (TSC). In this particular instance, the purpose of collection was to email you to schedule a treatment appointment in accordance with your bail conditions. TPH subsequently used your personal information to email the appointment to you. Therefore, I consider TPH has satisfied the requirements of NPP 2.1(a) as it used your personal information for the primary purpose of collection.
TPH also disclosed your personal information to Dr Calvird to confirm whether the emailed appointment had been sent to you and whether you had responded. I consider this disclosure was directly related to the primary purpose of emailing you to schedule an appointment as it was confirming that action had been completed. I am also of the view that you would reasonably expect such a disclosure as it is normal administrative process for support staff to advise whether they had carried out their tasks.
Therefore, I consider that TPH's use/disclosure of your personal information meets the requirements of NPP 2.1(a) and is permitted under the Act.
41 In relation to the alleged breach of NPP3, the delegate noted that NPP3 requires organisations to take "reasonable steps" to make sure the information it collects, uses or discloses is accurate, complete and up-to-date and that what are reasonable steps will depend on the organisation's particular circumstances. In some circumstances, the delegate said, "reasonable steps may mean taking no steps at all". The delegate went on to summarise the information before him and then formed a view that the TPH had not interfered with Dr Ogawa's privacy:
From the available information, it appears that TPH/Ms Gordge incorrectly advised Dr Calvird that an email appointment had been sent to you on 16 February 2009.
Dr Calvird subsequently advised the CDPP on 17 February 2009, that you had not responded to the email.
When Ms Gordge (TPH) found out the email had not transmitted successfully, she resent it to you on 17 February 2009 and received your prompt response. She advised Dr Calvird, who subsequently wrote to the CDPP and explained the situation.
On the available information, it appears that TPH provided incorrect information about you, to Dr Calvird, because of a one off mistake or error. When TPH became aware that an error had occurred, it took reasonable steps to correct the information as soon as practicable.
It is possible for a one-off error to occur but for an organisation to still meet the requirements of NPP 3.
Notwithstanding the possibility of human error, I do not consider it reasonable for TPH to carry out proactive checks to ensure that every email, sent at the direction of Dr Calvird, was actually sent. I consider it reasonable for TPH to assume that emails would be sent in the normal course. When asked by Dr Calvird whether she had sent the email, it was satisfactory for Ms Gordge to rely on her own memory of sending the email. It was not necessary for her to check whether the email had transmitted. I consider that, in the circumstances of this matter, reasonable steps amounted to TPH taking no steps and that, in this instance, TPH has met the requirements in NPP 3 of the Act.
42 As I have said, the delegate's letter of 18 February 2013 gave Dr Ogawa a further opportunity to comment before the Commissioner made a final decision. In a subsequent series of emails to the delegate between 26 February 2013 and 4 March 2013, Dr Ogawa raised six matters, which she styled as "questions". As her grounds of appeal raise particular issues in relation to these questions, it is necessary to describe them here.
43 First, Dr Ogawa asked if the delegate had "any case in mind" (by which she presumably meant an authority) which supported the delegate's proposition in the letter of 18 February 2013 that (as Dr Ogawa put it) "taking reasonable steps means sometimes taking no steps".
44 Second, having referred to the delegate's letter of 16 December 2010 (described at [31] of these reasons), Dr Ogawa said this:
Obviously the alleged disclosure was not something I consented to disclose and therefore you relied upon NPP2.1(b), the secondary purpose disclosure.
My question is whether there is any other case in which NPP 2.1(b) was decided to override the other statutory obligation of non-disclosure. I am particularly interested in whether there is a case in which a doctor was determined not to be liable for a breach of the confidentiality because the doctor's disclosure was deemed to be the secondary purpose disclosure.
45 Third, having referred to the delegate's statement in the letter of 18 February 2011 (described at [32] of these reasons) that from 29 January 2009, Dr Calvird was "authorised to inform the CDPP in accordance with [her] bail conditions", Dr Ogawa asked what was meant by that statement, that is, "what was Dr Calvird authorised to inform of to the CDPP [sic]?".
46 Fourth, Dr Ogawa again referred to the delegate's letter of 18 February 2011 and, in particular, the statement in it that the Commissioner considered that "subsequent disclosures by Dr Calvird to the CDPP are also made in the context of reporting under your bail conditions". Dr Ogawa asked whether that meant that in the Commissioner's opinion, the subsequent disclosure by Dr Calvird was not regulated by the National Privacy Principles of the Act, and if not, then which National Privacy Principle "authorises unauthorised disclosures of personal information" in the context of reporting under her bail conditions.
47 Fifth, Dr Ogawa asked whether the delegate was aware of the effect of particular provisions of the "Bail Act".
48 Sixth, Dr Ogawa referred to the delegate's proposition that the reasonable steps required by NPP3 may mean taking no steps at all. She returned again to her initial query regarding whether the Commissioner had any authority to support that proposition, and said this:
My next question is whether or not, in those cases you had in mind, the adverse effect of the date being inaccurate and the degree of intrusiveness if the organisation to verify the individual's personal information were considered. These two points are explained in the Information Sheet you referred to as the points to be considered to determine whether taking reasonable steps means taking no steps at all.
If in those cases you had in mind, these two points were not considered, then what was the reason to exclude these points from the consideration in those cases?
49 On 7 March 2013, the Commissioner's delegate wrote to Dr Ogawa in response to her emails between 28 February 2013 and 6 March 2013. The letter noted that Dr Ogawa's emails had raised a number of issues in relation to her complaint against Dr Calvird. The delegate said that as that complaint had been closed on 18 February 2011, and reviewed internally on 8 April 2011, she did not propose "to redress these issues again". The delegate also noted that Dr Ogawa had stated in her emails that she would ask more questions if the reply to her most recent questions did not "disclose the reasons for the OAIC's conclusions". In respect of that, the delegate stated that she considered that Dr Ogawa had been provided with the reasons for the Commissioner's decision in relation to her complaint against the TPH in the intent to decline letter of 18 February 2013.
50 The letter of 7 March 2013 gave Dr Ogawa a further opportunity to provide comments by 22 March 2013. Between 17 April 2013 and 1 May 2013, Dr Ogawa wrote a series of lengthy emails to the delegate which were in the nature of submissions canvassing a range of matters. On 29 May 2013, the Commissioner's delegate reached a final decision in respect of Dr Ogawa's complaint against the TPH. The delegate noted that, although some of Dr Ogawa's responses were received after the date by which the Commissioner had asked her to respond, she had considered the issues raised by Dr Ogawa in the emails. The delegate's decision was in these terms:
Dr Calvird's employment status
…
You claim the OAIC did not consider Dr Calvird's employment status to be an issue in your TPH complaint. As such, you assert it failed to determine or give reasons why Dr Calvird was not an employee of TPH, and erred in relying on a decision in your previous complaint about Dr Calvird (Ref: C14648), which you dispute. You claim an error of law in this regard.
I advise that, in response to the OAIC's inquiries, TPH confirmed that Dr Calvird is not an employee of TPH. TPH clarified that, as a consultant psychiatrist who is an independent contractor, Dr Calvird had admitting and consulting rights to TPH.
In the circumstances, the OAIC was satisfied with TPH's response and found no reason to question its veracity. We note your comments in this regard, but there is no information to suggest that Dr Calvird was an employee of TPH, and our view remains unchanged. The OAIC also previously noted that, as a health service provider, Dr Calvird has obligations under the Act in her own right.
As explained in [the delegate's] letter of 7 March 2013, the OAIC does not propose to reconsider the issues in relation to your previous complaint about Dr Calvird (Ref: C14648) …
NPP 3 - Data Quality issues
Dr Calvird
In your current complaint, you claim TPH provided false information when Dr Calvird and Ms Gordge disclosed personal information about you to the [CDPP] in February 2009.
The OAIC advised it was satisfied Dr Calvird was not an employee of, or in the service of, TPH for the purposes of the Act and that, in any case, it had previously determined that Dr Calvird did not interfere with your privacy in relation to this matter (Ref. C14G48).
You also maintain the OAIC has not considered NPP 3 issues in relation to the acts of Dr Calvird in your previous complaint (Ref: C14648). Briefly, you claim Dr Calvird disclosed personal information about you to the CDPP in February 2009 and that the information was false.
The OAIC has informed you that if you are concerned Dr Calvird misled the CDPP, with the result that this affected the outcome of your court proceedings, we are unable to assist you with this aspect of your complaint and you would need to seek legal advice. The OAIC advised that NPP 3 does not apply where there is an allegation of a deliberate intent to mislead by providing information that is false.
Again, where your matter involves your previous complaint against Dr Calvird, we do not propose to reconsider these issues as explained in our letter of 7 March 2013.
TPH/Ms Gordge
NPP 3 requires that TPH take reasonable steps to make sure the personal information it collects, uses or discloses is accurate, complete and up-to-date.
In this case the OAIC considered that TPH provided incorrect information about you, to Dr Calvird, because of a one-off error.
You claim the available information does not support our view that Ms Gordge, on behalf of TPH, gave incorrect information to Dr Calvird, as there is no information to suggest that Dr Calvird actually checked with Ms Gordge about whether an email was sent to you.
I note that, in her letter to the CDPP dated 23 February 2009, Dr Calvird advised that she checked with Ms Gordge about whether a response to the email had been received from you. At that time, Ms Gordge, to the best of her knowledge, thought the email drafted to you of 16 February 2009 had been successfully sent. However, this information was incorrect and Ms Gordge subsequently became aware, on the following day, that the email had not been transmitted.
On this basis, the OAIC remains of [the] view that TPH provided incorrect information to Dr Calvird because of a one-off error in relation to the email.
Reasonable steps
You submit that TPH did not take reasonable steps to ensure that your personal information was correct before it was disclosed to Dr Calvird, as required by NPP 3. This is on the basis that, even though TPH had the opportunity to check the email had been sent, it failed do so. You consider that when Dr Calvird checked with Ms Gordge as to whether you had responded to the email, Ms Gordge should have also checked that the email to which you were expected to respond had been sent.
I note that, when Dr Calvird asked Ms Gordge whether you had responded to the email, Ms Gordge was unaware that the email to you had not been transmitted. As previously advised, the OAIC does not consider it reasonable for TPH to require its employees to carry out proactive checks to ensure every email sent at the direction of a consultant is actually sent. The OAIC remains of the view that it was reasonable for TPH to assume that emails would be sent in the normal course of events.
What constitutes 'reasonable' steps in relation to NPP 3 will depend upon the individual circumstances of each situation. In some instances, such as in your matter, the reasonable steps required by NPP 3 can mean taking no steps at all. The OAIC acknowledges that you disagree on this point, however our view remains unchanged.
The OAIC is aware of your allegations related to the consequences of TPH's disclosure of incorrect information about you, involving the CDPP and your bail undertaking. However, the OAIC notes that remedies were available to address these consequences. For example, once Ms Gordge identified that the email had not been sent, she (and subsequently, Dr Calvird) took steps to correct the information that had been disclosed about you.
On this basis, the OAIC's view remains that in this instance it was reasonable for TPH to take no steps to confirm the email had been sent to you, before disclosing your information to Dr Calvird.
Therefore, for the reasons set out in [the 18 February 2013] letter, I have decided under s 41(1)(a) of the Act to decline to investigate your complaint on the grounds that TPH has not breached the Act. This file is now closed.
51 That decision is the third decision in respect of which Dr Ogawa now seeks review.